ITGAM and neoplasm: PMN-MDSCs are defined as CD11b+Ly6G+Ly6Clow, whereas M-MDSCs as CD11b+Ly6G−Ly6Chi, both of which are implicated in various aspects of immune regulation in diseases that involve chronic inflammation, such as neoplasias, infections, autoimmune diseases, and other pathologies (30).